MAI Wealth Advisors »

Tvardi Therapeutics shares owned by MAI Wealth Advisors

Quarter-by-quarter ownership of Tvardi Therapeutics (TVRD) shares owned by MAI Wealth Advisors from 13F filings

Historical chart of MAI Wealth Advisors investment in Tvardi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tvardi Therapeutics held by MAI Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tvardi Therapeutics by MAI Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $390 10 39.00
2025-06-30 $234 10 23.40

More positions owned by MAI Wealth Advisors

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple Call Call Option (Principal) (AAPL)
Microsoft Corp Call Call Option (Principal) (MSFT)
Ishares Tr Core S&p Mcp Etf (IJH)
Nvidia Corporation Call Call Option (Principal) (NVDA)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p Scp Etf (IJR)
Amazon Call Call Option (Principal) (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr S&p 500 Val Etf (IVE)
Broadcom Call Call Option (Principal) (AVGO)
Alphabet Call Call Option (Principal) (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for MAI Wealth Advisors

Top funds holding Tvardi Therapeutics

Slate Path Capital
Vanguard Group
BlackRock
683 Capital Management
Vestal Point Capital
Geode Capital Management
Invesco
FMR
Parkman Healthcare Partners
State Street Corporation
UBS Group
Farallon Capital Management
Northern Trust
Renaissance Technologies
Boothbay Fund Management

View all funds holding Tvardi Therapeutics